Debate: Is there an optimal treatment for refractory colorectal cancer? - TAS-102 or regorafenib - 100004

Spotlight
Video

Debate: Is there an optimal treatment for refractory colorectal cancer? - TAS-102 or regorafenib

imedex has 1221 videos Subscribe Here

Loading........
Description: In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Eric Van Cutsem argues that TAS-102 or regorafenib are the optimal treatment for refractory colorectal cancer.

Earn CME Credit for a related activity: http://elc.imedex.com/ELC/S...

© 2017 Imedex, LLC.
Shared By : imedex
Posted on : 10/13/17
Added : 6 months ago